Application of urine SH3 domain glutamic acid-rich-like protein 3 protein and polypeptide fragments thereof in lung adenocarcinoma

A polypeptide fragment and domain technology, which is applied to the application of urine SH3 domain glutamate-enriched protein-like protein 3 protein and its polypeptide fragments in lung adenocarcinoma, can solve the problem of lack, SH3 domain interaction, and inconsistency. It has problems such as gluten oxidoreductase activity, and achieves the effect of convenient storage.

Active Publication Date: 2018-05-11
张曼
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in SH3BGRL3, SH3BGRL3 lacks the super-secondary structure interacting with the SH3 domain that both SH3BGRL and SH3BGRL2 have, so it cannot interact with the SH3 domain, suggesting that the function of SH3BGRL3 should be significantly different from the other two proteins
In addition to the proteins of this family, the SH3BGRL3 protein is also highly homologous to glutaredoxin 1 and glutaredoxin 3 in E.coli in sequence, but lacks the inherent CXXC super secondary structure of glutaredoxin at the enzyme active site, so it is destined not to Has gluten oxidoreductase activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of urine SH3 domain glutamic acid-rich-like protein 3 protein and polypeptide fragments thereof in lung adenocarcinoma
  • Application of urine SH3 domain glutamic acid-rich-like protein 3 protein and polypeptide fragments thereof in lung adenocarcinoma
  • Application of urine SH3 domain glutamic acid-rich-like protein 3 protein and polypeptide fragments thereof in lung adenocarcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1 Urine Specimen Collection and Processing

[0020] Randomly cleaned midstream urine samples were collected from 34 patients with lung adenocarcinoma (Beijing Shijitan Hospital Affiliated to Capital Medical University), centrifuged within 2 hours (1500rpm, 5min), and the supernatant was retained. Store in a -80°C refrigerator after aliquoting. The normal control group consisted of 36 cases (Physical Examination Center, Beijing Shijitan Hospital Affiliated to Capital Medical University). For details, please refer to the following table 1:

[0021] Table 1. Clinical data of the 2 groups

[0022]

Embodiment 2

[0023] Example 2 Magnetic Bead Purification and Isolation of Peptides from Urine Specimens

[0024] Take out the urine sample from the -80°C refrigerator, rethaw at 4°C, centrifuge (3000rpm, 10min), and take the supernatant for later use. Equilibrate Weak Cationic Magnetic Beads (MB-WCX) at room temperature and mix the magnetic bead suspension by hand. Add 10ul of MB-WCX and 10ul of magnetic bead binding buffer into the sample tube, pipette the sample gun up and down to mix well to avoid foaming. Add 5 ul of urine supernatant to the sample tube, mix well and let stand on the magnetic stand for 1 minute to separate the magnetic beads from the suspended liquid. Use a sampling gun to remove the suspended clear liquid, and the tip of the gun should avoid contact with the magnetic beads to avoid absorbing the magnetic beads. Add 100ul of magnetic bead washing buffer into the sample tube, mix well, and then place the sample tube on the magnetic stand for 1 minute, the magnetic b...

Embodiment 3

[0025] Example 3 Spot Targeting and Peptide Spectrum Generation of Urine Specimens

[0026]After calibrating the instrument with a standard, mix 1 μl of eluate with 10 μl of matrix (0.3% α-cyano-4-hydroxycinnamic acid, HCCA), and take 1 μl to spot on the Anchorchip (Autoflex MALDI TOF, Bruker-Dalton) target plate and dry at room temperature. The sample is ionized by nitrogen laser irradiation and then subjected to mass spectrometry analysis, collecting data in the range of 1000-10000 Da, and obtaining a mass spectrogram composed of protein peaks with different mass-to-charge ratios. For each MALDI crystallization point, a total of 400 laser irradiations (50 times for each crystallization point at 8 different positions) were irradiated, and the average value represented one sample, so as to obtain the peptide maps of all samples. The mass spectrograms of the normal control group and lung adenocarcinoma group were analyzed by ClinProTools2.1 analysis software, and the differe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides application of urine SH3 domain glutamic acid-rich-like protein 3 protein (SH3 domain-binding glutamic acid-rich-like protein 3 protein, SH3BGRL3, also known as SH3 domain-binding protein 1) and polypeptide fragments thereof, and specifically provides application of the urine SH3 domain glutamic acid-rich-like protein 3 protein and the polypeptide fragments thereof in preparation of a preparation for detecting and assisting diagnosis of lung adenocarcinoma. Researches confirm that compared with normal control and a lung adenocarcinoma patient group, different polypeptide fragments of the SH3 domain glutamic acid-rich-like protein 3 protein are expressed in the urine of a patient with the lung adenocarcinoma, and can be used for the detecting and assisting diagnosis of the lung adenocarcinoma The advantages of non-invasive acquisition, large-scale repeated sampling, and convenient storage of a urine sample can be played. The urine sample is used to detectthe SH3 domain glutamic acid-rich-like protein 3 protein and the polypeptide fragments thereof.

Description

technical field [0001] The present invention relates to new uses of urinary SH3 domain glutamic acid-enriched protein 3 protein and its polypeptide fragments, in particular to the use of urinary SH3 domain glutamic acid-enriched protein 3 protein and its polypeptide fragments in the diagnosis and treatment of lung adenocarcinoma in the application. Background technique [0002] Lung cancer is one of the tumors with the highest morbidity and mortality worldwide. The latest WHO statistics show that 1.59 million patients die of lung cancer every year worldwide. Lung cancer can be divided into small cell lung cancer (SCLC) and non-small lung cancer (NSCLC) according to pathological types, and NSCLC is further divided into squamous cell carcinoma, adenocarcinoma, large cell carcinoma, and sarcomatoid carcinoma. Wait. With the deepening of lung cancer research, NSCLC is divided into squamous cell carcinoma and non-squamous non-small cell lung cancer according to the existence o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68G01N33/574
Inventor 张曼王珊珊王巍伟雷婷
Owner 张曼
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap